AI assistant
Sending…
Iterum Therapeutics plc — Director's Dealing 2018
Nov 1, 2018
34796_dirs_2018-11-01_3e823d52-f108-441f-88e5-f2a73fe17be5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Iterum Therapeutics plc (ITRM)
CIK: 0001659323
Period of Report: 2018-10-30
Reporting Person: Chin Mark (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-10-30 | Ordinary Shares | P | 58000 | $6.10 | Acquired | 1089903 | Indirect |
Footnotes
F1: The Reporting Person is an Investment Director for Arix Bioscience Holdings Ltd.
More from Iterum Therapeutics plc
Delisting Announcement
2026
Mar 31
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Mar 3
Delisting Announcement
2026
Mar 2
Declaration of Voting Results & Voting Rights Announcements
2026
Feb 18
Proxy Solicitation & Information Statement
2026
Jan 2
Proxy Solicitation & Information Statement
2025
Dec 23
Delisting Announcement
2025
Dec 12
Director's Dealing
2025
Nov 20
Interim / Quarterly Report
2025
Nov 14